{"entity":{"type":"insider","cik":"0001569077","url":"/insider/0001569077","json_url":"/insider/0001569077.json","name":"Weisblum Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":22,"first":"2021-05-17","last":"2025-12-16","span_basis":"filed_date"},"name_variants":[{"name":"Weisblum Eric","source":"filing","n_filings":22,"first_seen":"2021-05-17","last_seen":"2025-12-16"}],"transactions":[{"id":4458050,"accession":"0001213900-25-122429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-122429","line_url":"/filing/0001213900-25-122429","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.415,"price_display":"0.42","price_state":"stated","total_value":2075.0,"total_display":"2,075.00","total_whole":"2,075","shares_owned_after":216932.0,"shares_owned_after_display":"216,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider","n_lines":2},{"id":4703082,"accession":"0001213900-25-113743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-113743","line_url":"/filing/0001213900-25-113743#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.365,"price_display":"0.36","price_state":"stated","total_value":365.0,"total_display":"365.00","total_whole":"365","shares_owned_after":211932.0,"shares_owned_after_display":"211,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-21","scope":"insider"},{"id":4703077,"accession":"0001213900-25-113743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-113743","line_url":"/filing/0001213900-25-113743#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":370.0,"total_display":"370.00","total_whole":"370","shares_owned_after":210932.0,"shares_owned_after_display":"210,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider"},{"id":4579886,"accession":"0001213900-25-113104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-113104","line_url":"/filing/0001213900-25-113104#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":0.405,"price_display":"0.40","price_state":"stated","total_value":1822.5,"total_display":"1,822.50","total_whole":"1,823","shares_owned_after":209932.0,"shares_owned_after_display":"209,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-20","scope":"insider"},{"id":4579881,"accession":"0001213900-25-113104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-113104","line_url":"/filing/0001213900-25-113104#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":0.4033,"price_display":"0.40","price_state":"stated","total_value":3024.75,"total_display":"3,024.75","total_whole":"3,025","shares_owned_after":205432.0,"shares_owned_after_display":"205,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4299587,"accession":"0001213900-25-048304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-048304","line_url":"/filing/0001213900-25-048304#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4329,"price_display":"0.43","price_state":"stated","total_value":4329.0,"total_display":"4,329.00","total_whole":"4,329","shares_owned_after":197932.0,"shares_owned_after_display":"197,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-28","scope":"insider"},{"id":3132670,"accession":"0001213900-24-109363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-109363","line_url":"/filing/0001213900-24-109363#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.8387,"price_display":"0.84","price_state":"stated","total_value":2096.75,"total_display":"2,096.75","total_whole":"2,097","shares_owned_after":187932.0,"shares_owned_after_display":"187,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":2889132,"accession":"0001213900-24-101610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-101610","line_url":"/filing/0001213900-24-101610#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":2250.0,"total_display":"2,250.00","total_whole":"2,250","shares_owned_after":185432.0,"shares_owned_after_display":"185,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-22","scope":"insider"},{"id":2889125,"accession":"0001213900-24-101610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-101610","line_url":"/filing/0001213900-24-101610#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.95,"price_display":"0.95","price_state":"stated","total_value":2375.0,"total_display":"2,375.00","total_whole":"2,375","shares_owned_after":182932.0,"shares_owned_after_display":"182,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2436486,"accession":"0001213900-24-052354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-052354","line_url":"/filing/0001213900-24-052354#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4438.0,"shares_display":"4,438","price_per_share":1.11,"price_display":"1.11","price_state":"stated","total_value":4926.18,"total_display":"4,926.18","total_whole":"4,926","shares_owned_after":180432.0,"shares_owned_after_display":"180,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider"},{"id":2436479,"accession":"0001213900-24-052354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-052354","line_url":"/filing/0001213900-24-052354#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":562.0,"shares_display":"562","price_per_share":1.08,"price_display":"1.08","price_state":"stated","total_value":606.96,"total_display":"606.96","total_whole":"607","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-13","scope":"insider"},{"id":2178944,"accession":"0001213900-24-031159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-031159","line_url":"/filing/0001213900-24-031159#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":812.0,"total_display":"812.00","total_whole":"812","shares_owned_after":175432.0,"shares_owned_after_display":"175,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-05","filed_date":"2024-04-08","scope":"insider"},{"id":2178940,"accession":"0001213900-24-031159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-031159","line_url":"/filing/0001213900-24-031159#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":1176.0,"total_display":"1,176.00","total_whole":"1,176","shares_owned_after":175032.0,"shares_owned_after_display":"175,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":3171374,"accession":"0001213900-24-028973","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-028973","line_url":"/filing/0001213900-24-028973#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":2101.0,"total_display":"2,101.00","total_whole":"2,101","shares_owned_after":174432.0,"shares_owned_after_display":"174,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider"},{"id":3171367,"accession":"0001213900-24-028973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-028973","line_url":"/filing/0001213900-24-028973#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3408.0,"shares_display":"3,408","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":6611.52,"total_display":"6,611.52","total_whole":"6,612","shares_owned_after":173332.0,"shares_owned_after_display":"173,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":8157012,"accession":"0001213900-23-097689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-097689","line_url":"/filing/0001213900-23-097689#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":1.61,"price_display":"1.61","price_state":"stated","total_value":322.0,"total_display":"322.00","total_whole":"322","shares_owned_after":169924.0,"shares_owned_after_display":"169,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-21","scope":"insider"},{"id":8157008,"accession":"0001213900-23-097689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-097689","line_url":"/filing/0001213900-23-097689#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":815.0,"total_display":"815.00","total_whole":"815","shares_owned_after":169724.0,"shares_owned_after_display":"169,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-21","scope":"insider"},{"id":8117923,"accession":"0001213900-23-096606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-096606","line_url":"/filing/0001213900-23-096606#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":1368.0,"total_display":"1,368.00","total_whole":"1,368","shares_owned_after":169224.0,"shares_owned_after_display":"169,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-18","scope":"insider"},{"id":8117919,"accession":"0001213900-23-096606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-096606","line_url":"/filing/0001213900-23-096606#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":300.0,"total_display":"300.00","total_whole":"300","shares_owned_after":168324.0,"shares_owned_after_display":"168,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":7924487,"accession":"0001213900-23-094145","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-094145","line_url":"/filing/0001213900-23-094145#line-3","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":324.0,"shares_display":"324","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":440.64,"total_display":"440.64","total_whole":"441","shares_owned_after":168124.0,"shares_owned_after_display":"168,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-07","scope":"insider"},{"id":7924484,"accession":"0001213900-23-094145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-094145","line_url":"/filing/0001213900-23-094145#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76.0,"shares_display":"76","price_per_share":1.34,"price_display":"1.34","price_state":"stated","total_value":101.84,"total_display":"101.84","total_whole":"102","shares_owned_after":167800.0,"shares_owned_after_display":"167,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-07","scope":"insider"},{"id":7924481,"accession":"0001213900-23-094145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-094145","line_url":"/filing/0001213900-23-094145#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":834.0,"total_display":"834.00","total_whole":"834","shares_owned_after":167724.0,"shares_owned_after_display":"167,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-07","scope":"insider"},{"id":8708104,"accession":"0001213900-23-091665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-091665","line_url":"/filing/0001213900-23-091665#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":1530.0,"total_display":"1,530.00","total_whole":"1,530","shares_owned_after":167124.0,"shares_owned_after_display":"167,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-11-30","scope":"insider"},{"id":8708102,"accession":"0001213900-23-091665","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-091665","line_url":"/filing/0001213900-23-091665#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.57,"price_display":"1.57","price_state":"stated","total_value":1570.0,"total_display":"1,570.00","total_whole":"1,570","shares_owned_after":166124.0,"shares_owned_after_display":"166,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-11-30","scope":"insider"},{"id":7904918,"accession":"0001213900-23-090270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-090270","line_url":"/filing/0001213900-23-090270#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":1.78,"price_display":"1.78","price_state":"stated","total_value":445.0,"total_display":"445.00","total_whole":"445","shares_owned_after":165124.0,"shares_owned_after_display":"165,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-27","scope":"insider"},{"id":7904915,"accession":"0001213900-23-090270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-090270","line_url":"/filing/0001213900-23-090270#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":1.68,"price_display":"1.68","price_state":"stated","total_value":672.0,"total_display":"672.00","total_whole":"672","shares_owned_after":164874.0,"shares_owned_after_display":"164,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-22","filed_date":"2023-11-27","scope":"insider"},{"id":8406900,"accession":"0001213900-23-089570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-089570","line_url":"/filing/0001213900-23-089570#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":468.0,"total_display":"468.00","total_whole":"468","shares_owned_after":164474.0,"shares_owned_after_display":"164,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8406897,"accession":"0001213900-23-089570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-089570","line_url":"/filing/0001213900-23-089570#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4050.0,"shares_display":"4,050","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":6480.0,"total_display":"6,480.00","total_whole":"6,480","shares_owned_after":164174.0,"shares_owned_after_display":"164,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-22","scope":"insider"},{"id":8228016,"accession":"0001213900-23-088890","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-088890","line_url":"/filing/0001213900-23-088890#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800.0,"shares_display":"1,800","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":2772.0,"total_display":"2,772.00","total_whole":"2,772","shares_owned_after":160124.0,"shares_owned_after_display":"160,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8228011,"accession":"0001213900-23-088890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-088890","line_url":"/filing/0001213900-23-088890#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":1463.0,"total_display":"1,463.00","total_whole":"1,463","shares_owned_after":158324.0,"shares_owned_after_display":"158,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8191328,"accession":"0001213900-23-041179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-041179","line_url":"/filing/0001213900-23-041179#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":2.107,"price_display":"2.11","price_state":"stated","total_value":1053.5,"total_display":"1,053.50","total_whole":"1,054","shares_owned_after":157724.0,"shares_owned_after_display":"157,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-18","scope":"insider"},{"id":8191322,"accession":"0001213900-23-041179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-041179","line_url":"/filing/0001213900-23-041179#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":5150.0,"total_display":"5,150.00","total_whole":"5,150","shares_owned_after":157224.0,"shares_owned_after_display":"157,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":6708568,"accession":"0001213900-22-081513","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-22-081513","line_url":"/filing/0001213900-22-081513#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130.0,"shares_display":"130","price_per_share":2.72,"price_display":"2.72","price_state":"stated","total_value":353.6,"total_display":"353.60","total_whole":"354","shares_owned_after":154854.0,"shares_owned_after_display":"154,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-20","scope":"insider"},{"id":6708565,"accession":"0001213900-22-081513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-081513","line_url":"/filing/0001213900-22-081513#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":2.6815,"price_display":"2.68","price_state":"stated","total_value":536.3,"total_display":"536.30","total_whole":"536","shares_owned_after":154724.0,"shares_owned_after_display":"154,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-20","scope":"insider"},{"id":6157183,"accession":"0001213900-22-080102","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-22-080102","line_url":"/filing/0001213900-22-080102#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":263.0,"shares_display":"263","price_per_share":3.1699,"price_display":"3.17","price_state":"stated","total_value":833.6837,"total_display":"833.68","total_whole":"834","shares_owned_after":154524.0,"shares_owned_after_display":"154,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6157180,"accession":"0001213900-22-080102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-080102","line_url":"/filing/0001213900-22-080102#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":487.0,"shares_display":"487","price_per_share":3.0676,"price_display":"3.07","price_state":"stated","total_value":1493.9212,"total_display":"1,493.92","total_whole":"1,494","shares_owned_after":154261.0,"shares_owned_after_display":"154,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-13","filed_date":"2022-12-15","scope":"insider"},{"id":6659217,"accession":"0001213900-22-033752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-22-033752","line_url":"/filing/0001213900-22-033752#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO, CFO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13080.0,"shares_display":"13,080","price_per_share":0.1147,"price_display":"0.11","price_state":"stated","total_value":1500.276,"total_display":"1,500.28","total_whole":"1,500","shares_owned_after":7724643.0,"shares_owned_after_display":"7,724,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":4850404,"accession":"0001213900-21-065395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-065395","line_url":"/filing/0001213900-21-065395#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":0.1377,"price_display":"0.14","price_state":"stated","total_value":2409.75,"total_display":"2,409.75","total_whole":"2,410","shares_owned_after":7711563.0,"shares_owned_after_display":"7,711,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":4850398,"accession":"0001213900-21-065395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-065395","line_url":"/filing/0001213900-21-065395#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.1554,"price_display":"0.16","price_state":"stated","total_value":777.0,"total_display":"777.00","total_whole":"777","shares_owned_after":7694063.0,"shares_owned_after_display":"7,694,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-15","scope":"insider"},{"id":5538784,"accession":"0001213900-21-026675","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-21-026675","line_url":"/filing/0001213900-21-026675#line-3","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO, CFO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":90.0,"total_display":"90.00","total_whole":"90","shares_owned_after":58114.0,"shares_owned_after_display":"58,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-22","filed_date":"2021-05-17","scope":"insider"},{"id":5538781,"accession":"0001213900-21-026675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-21-026675","line_url":"/filing/0001213900-21-026675#line-2","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO, CFO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":76.0,"total_display":"76.00","total_whole":"76","shares_owned_after":57914.0,"shares_owned_after_display":"57,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2021-05-17","scope":"insider"},{"id":5538778,"accession":"0001213900-21-026675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-21-026675","line_url":"/filing/0001213900-21-026675#line-1","is_derivative":false,"issuer_cik":"0001514183","issuer_name":"Silo Pharma, Inc.","issuer_ticker":"SILO","issuer_name_source":null,"issuer_url":"/issuer/0001514183","owner_cik":"0001569077","owner_name":"Weisblum Eric","owner_display_name":"Weisblum Eric","owner_url":"/insider/0001569077","role":"Director, Officer (CEO, CFO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO, CFO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57714.0,"shares_display":"57,714","price_per_share":0.002,"price_display":"0.00","price_state":"stated","total_value":115.428,"total_display":"115.43","total_whole":"115","shares_owned_after":57714.0,"shares_owned_after_display":"57,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2021-05-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":43,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001514183","name":"Silo Pharma, Inc.","url":"/issuer/0001514183","role":"Director, Officer (Chief Executive Officer)","n_filings":22,"first_seen":"2021-05-17","last_seen":"2025-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001569077","retrieved_at":"2026-08-27T11:03:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}